[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  M [@bio_clouseau](/creator/twitter/bio_clouseau) on x 19.6K followers Created: 2021-06-21 11:20:39 UTC Interesting comment since $GSK has been mainly spending on late oncology drugs like $TSRO. And most of their other deals have been less extravagant than say $GILD $MRK $BMY. Quite difficult to restart an oncology pipeline after predecessor sells off most of it  XX engagements  **Related Topics** [$gild](/topic/$gild) [$tsro](/topic/$tsro) [drugs](/topic/drugs) [$gsk](/topic/$gsk) [gsk plc](/topic/gsk-plc) [stocks healthcare](/topic/stocks-healthcare) [gilead sciences](/topic/gilead-sciences) [$mrk](/topic/$mrk) [Post Link](https://x.com/bio_clouseau/status/1406935087938146305)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
M @bio_clouseau on x 19.6K followers
Created: 2021-06-21 11:20:39 UTC
Interesting comment since $GSK has been mainly spending on late oncology drugs like $TSRO. And most of their other deals have been less extravagant than say $GILD $MRK $BMY. Quite difficult to restart an oncology pipeline after predecessor sells off most of it
XX engagements
Related Topics $gild $tsro drugs $gsk gsk plc stocks healthcare gilead sciences $mrk
/post/tweet::1406935087938146305